Biomarker for diagnosing nonspecific interstitial pneumonia
暂无分享，去创建一个
The principal problem addressed by the present invention is the provision of a biomarker that allows simple, high-precision clinical or histopathological diagnosis of nonspecific interstitial pneumonia. At least one antibody, contained in a blood sample, selected from among a group consisting of an anti-Mx1 antibody, an anti-NINJ2 antibody, an anti-DCX antibody, an anti-C10orf49 antibody, an anti-ZMAT4 antibody, an anti-CDC42SE1 antibody, and an anti-GPT2 antibody can serve as a biomarker for nonspecific interstitial pneumonia (NSIP).
[1] I. Bittmann,et al. [Non-specific interstitial pneumonia (NSIP)]. , 2011, Pneumologie.
[2] J. Fujita,et al. Detection of antivimentin antibody in sera of patients with idiopathic pulmonary fibrosis and non‐specific interstitial pneumonia , 2002, Clinical and experimental immunology.